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Abstract Photochemically induced cerebral ischemia is an
easy-manipulated, reproducible, relatively noninvasive, and
lesion controllable model for translational study of ischemic
stroke. In order to longitudinally investigate the characteriza-
tion of the model, magnetic resonance imaging, 18F-2-deoxy-
glucose positron emission tomography, fluorescence, and bio-
luminescence imaging system were performed in correlation
with triphenyl tetrazolium chloride (TTC), hematoxylin-eosin
staining, and immunohistochemistry examinations of glial fi-
brillary acidic protein, CD68, NeuN, von willebrand factor,
and α-smooth muscle actin in the infarct zone. The results
suggested that the number of inflammatory cells, astrocytes,
and neovascularization significantly elevated in peri-infarct
region from day 7 and a belt of macrophage/microglial and
astrocytes was formed surrounding infarct lesion at day 14.
Both vasogenic and cytotoxic edema, as well as blood brain-
barrier leakage, occurred since day 1 after stroke induction
and gradually attenuated with time. Numerous cells other than
neuronal cells infiltrated into infarct lesion, which resulted in
no visible TTC negative regional existence at day 14.
Furthermore, recovery of cerebral blood flow and glucose
utilization in peri-infarct zone were noted and more remark-
ably than that in infarct core following the stroke progression.
In conclusion, these characterizations may be highly benefi-
cial to the development of therapeutic strategies for ischemic
stroke.
Keywords Photothrombotic stroke .Multimodality imaging
Introduction
Cerebral ischemia accounts for 80 % of all human strokes and
has a major impact on the public health [1]. It causes primary
neuronal death in the ischemic region and leads to delayed
neuronal degeneration in the penumbra [2]. Stroke disables
the patients more than it kills. This fact has led a recent effort
to develop strategies for neural repair after stroke. Several
small animal models of stroke have been developed to identify
mechanisms of cerebral ischemia for developing novel
recanalyzing, neuroprotective, neuroregenerative, or anti-
inflammatory drugs at a preclinical level [3, 4]. Among them,





1 State Key Laboratory of Quality Research in Chinese Medicine,
Faculty of Chinese Medicine, Macau University of Science and
Technology, Avenida Wai Long, Taipa 999078, Macau
2 Biomedical Imaging Research Center, National Yang-Ming
University, Taipei, Taiwan
3 Department of Biomedical Imaging and Radiological Sciences,
National Yang-Ming University, Taipei, Taiwan
4 Institute of Clinical Medicine, National Yang-Ming University,
Taipei, Taiwan
5 Department of Medical Engineering, National Yang-Ming
University, Taipei, Taiwan
6 Department of Radiology, Taipei Veterans General Hospital,
Taipei, Taiwan
7 Department of Biomedical Imaging and Radiological Sciences,
Kaohsiung Medical University, Kaohsiung, Taiwan
8 Molecular andGenetic Imaging Core/TaiwanMouse Clinic, National
Comprehensive Mouse Phenotyping and Drug Testing Center,
Taipei, Taiwan
9 Department of Nuclear Medicine and National PET/Cyclotron
Center, Taipei Veterans General Hospital, Taipei, Taiwan
Transl. Stroke Res.
DOI 10.1007/s12975-016-0512-4
middle cerebral artery occlusion (MCAo) by an intraluminal
filament technique is the most widely used method [5].
Another approach that is technically simpler involves induc-
tion of cerebral ischemia and infarction in the cortical vascu-
lature of rats by photochemical reaction triggered by systemic
administration of rose bengal (disodium tetraiodo-tetrachloro-
fluorescein) and focal illumination of the brain [6].
Illumination leads to production of singlet oxygen via dye
triplet energy transfer, which in turn induces peroxidative
damage to the endothelium and a vasoconstriction.
Consequently, platelet aggregation is produced, with the de-
velopment of a thrombus and vascular occlusion, and a distal
territory ischemia is formed [6–8]. Rats with small infarct
volume induced by this method have low mortality, and even
performed on aged rats, the mortality of rats with
photothrombotic stroke remained much lower than those with
global, permanent stroke [9, 10]. An animal model of cerebral
ischemia, providing both reproducibility and precise control
of lesion size, is critical for translational studies. MCAo pro-
duces large ischemic lesions of varying size, which may be
considered as a burden to research conducting. Further,
MACo lacks the participation of platelet aggregation which
is primary initiator of clinical ischemic events [11]. The
photothrombotic model not only overcomes the drawbacks
of MCAo but can also be used to characterize inflammatory
response and apoptosis following thrombosis [12–14] and to
monitor structural and functional plasticity of neurons [15].
Current managements of acute stroke include restoring ce-
rebral blood flow (CBF) to ischemic penumbral area by
thrombolytic therapy, interventional procedures, surgery,
and/or cell-based therapy to enhance tissue repair and func-
tional recovery after ischemic stroke [16–18]. Noninvasive
imaging modalities, such as magnetic resonance imaging
(MRI) and positron emission tomography (PET), are promis-
ing for investigating the evolution of stroke, confirming the
validity of models, monitoring the effect of revascularization
interventions, and evaluating the efficacy of novel therapeutic
drugs [19–23]. MRI has been used in several preclinical stud-
ies of stroke using MCAo model [8, 20, 21]. When ischemic
brain injury occurs, glucose metabolism changes in the infarct
and peri-infarct regions. This was demonstrated in earlier re-
ports using 14C-2-deoxy-D-glucose (14C-2-DG) autoradiogra-
phy for the study of photochemically induced ischemic stroke
[24] and MCAo model [25]. However, method of 14C-2-DG
with autoradiography is limited for in vivo longitudinal eval-
uation of glucose metabolism on the same animal. Until re-
cently, 18F-2-deoxy-glucose (FDG) PET imaging was used to
evaluate glucose metabolism in transient and permanent
MCAo models of rats [26, 27]. The powerful imaging tools
of 18F-FDG/PET and MRI offer the information of metabolic
changes, lesion structure, edematous and CBF status, respec-
tively. In order to characterize the temporal evolution of stroke
lesion induced by photothrombotic method in 14 days, 18F-
FDG/PET, T2-weighted image (T2WI), perfusion-weighted
image (PWI), and diffusion-weighted image (DWI) were per-
formed to measure cerebral glucose metabolism, edematous
lesion, tissue perfusion, and water diffusion, respectively. This
image information was further correlated with the cellular and
molecular analysis including tissue viability, morphological
changes, inflammatory response, astrocyte scar formation,
neovascularization, and blood-brain barrier (BBB) permeabil-
ity, performed by 2, 3, 5-triphenyl tetrazolium chloride (TTC),
hematoxylin-eosin (H&E) staining, immunohistochemistry
(IHC) staining, and ex vivo Evans blue (EB) imaging in the
photochemically induced stroke model of rat.
Materials and Methods
Animals and Study Design
Seven-week-old male Sprague-Dawley rats were kept under
standardized condition (12–12-h light-dark cycle, with free
access to food and water). The animals received serial MRI
and 18F-FDG PET/computed tomography (CT) imaging at
day 1, 3, 7, and 14 after photothrombotic stroke induction.
For TTC, H&E, IHC, and EB staining, rats were sacrificed
at day 1, 3, 7, and 14 after stroke induction, and intact brain
was carefully removed for subsequent manipulation. All ani-
mal experiments in this study were conducted according to the
guidelines set by the National Laboratory Animal Center and
approved by the Institutional Animal Care and Use
Committee of National Yang-Ming University and Macau
University of Science and Technology. Reporting of this work
complies with Animal Research: Reporting in Vivo
Experiments (ARRIVE) guidelines.
Photochemically Induced Stroke
Rats were temporarily anesthetized with isoflurane (induc-
tion 3.0 % in air) followed by intramuscular injection of
Dexdomitor and Zoletil 50 mixture (1:1) (Orion, Finland
and Virbac, France, respectively) with a dose of 100 μl
per 300 g body weight and placed in a stereotaxic frame
(Narishige Instruments, Tokyo, Japan). After a small incision
was made on the scalp, a craniotomic window (3mm × 6mm)
was made over the somatosensory cortex with the center at
the coordinate of 1 mm rostrally from the bregma and
3.5 mm lateral to the midline. A laser beam of 1.5 mm
diameter and 532 nm wavelength (GPD105-M-12, Onset
Electro-Optics, Taiwan) was stereotactically positioned at
the middle of the craniotomic window and illuminated for
20 min. During the first 2 min of illumination, rose bengal
(2 ml/kg body weight, concentration: 10 mg/ml saline) was
slowly injected through the tail vein. Two control groups
were performed following full procedure except for laser
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illumination or rose bengal injection. All rats after stroke
induction were able to survive until they were sacrificed at
the end point in this study.
Regional Cerebral Vasculature Examination with Laser
Speckle Contrast Imaging
Laser speckle contrast imaging (LSCI) is a technique in which
coherent light incidence on a surface produces a reflected
speckle pattern that is related to the underlying movement of
optical scatters, such as red blood cells, indicating blood flow
[28]. Before and after thrombosis was induced by photochem-
ical method, regional cerebral vasculature was examined by
LSCI. Briefly, a moorFLPI-2 Full-Field Laser Perfusion
Imager (Moor Instruments, Axminster, UK) was placed at
the center of cranial window on the somatosensory cortex
where the laser beam illuminated. Before and after laser illu-
mination, the laser speckle imaging was acquired with 25-Hz
sampling frequency, 1 frame/s, 580 × 752 pixels resolution,
and zoom size of 5.6 mm × 7.5 mm.
TTC Assay and H&E Staining
At day 1, 3, 7, and 14 after initiation of photothrombotic
stroke, selected rats (n = 3 at each day) were sacrificed by
overdose injection of pentobarbital for tissue viability and
histopathological examinations. Following sacrifice, fresh
brain was removed from the skull, washed in iced phosphate
buffer saline (PBS), and placed in a brain mold. Coronal sec-
tions of 1 mm in thickness were cut through the cerebrum and
placed in 2% TTC (Sigma) for 15min in a 37 °C incubator for
the macroscopic determination of tissue viability. All sections
were photographed for delineation of infarct as revealed with
TTC. The brain sections were then fixed with 10 % formalin
and processed with H&E staining for microscopic
examination.
Immunohistochemical Staining
Paraffin-embedded rat brain tissues with thrombotic stroke at
day 1, 3, 7, and 14 (n = 3 at each time point) were cut into
5-μm section slices. After 1-h blocking (10 % normal serum,
1 % bovine serum albumin [BSA], and 0.025 % TritonX-100
in tris-HCL buffered solution [TBS]), sections were incubated
overnight at 4 °C with the following primary antibodies (pre-
diluted in TBS containing 1 % BSA): anti-alpha smooth mus-
cle actin (αSMA, 1:100, ab7817, Abcam), anti-von
Willebrand Factor (vWF, 1:100, ab6994, Abcam), anti-glial
fibrillary acidic protein (GFAP, 1:200, ab53554, Abcam),
anti-CD68 (1:100, mab6564, Abnova), and anti-NeuN
(1:200 #52283, Arigobio). After being rinsed with TBS-
0.1 % Tween-20, tissue sections were detected using horse-
radish peroxidase-conjugated secondary antibodies and the
DAKO Dual Link system (DAKO, K4065) with 2 % 3,3-
diaminobenzidine. The images were photographed by the
Aperio Image Scope 12.3 (Leica).
T2WI, DWI, and PWI Examinations by Magnetic
Resonance Imaging
BioSpec-70/30 7Tsystem (Bruker, Ettlingen, Germany) using
a birdcage head-coil of 75 mm inner diameter for radio fre-
quency (RF) transmission and a 20 mm diameter surface coil
for reception was used for MRI experiment. The same rat at
day 1, 3, 7, and 14 after thrombotic stroke was anesthetized
with initial inhalation of 4 % isoflurane for 3 min and main-
tained with 2 % isoflurane in a mixture of 20 % oxygen and
80 % room air. Prior to imaging, rats under anesthesia were
placed in the stereotaxic holder of MRI machine equipped
with a heating system to maintain body temperature and a
pressure detector to monitor respiration. MRI data sets
consisting TWI, DWI, and PWI were acquired at correspond-
ing time points. T2WIs were acquired with a multislice
multiecho Carr, Purcell, Meiboom, Gill (CPMG) sequence:
r epe t i t i on t ime (TR) = 2500 msec , e cho t ime
( T E ) = 3 3 m s e c , 1 6 e c h o e s , f i e l d o f v i e w
(FOV) = 25 × 25 mm2, slice thickness = 1 mm, ma-
trix = 256 × 256. Eight coronal and eight horizontal slices
were acquired covering a volume extending 10 mm in the
rostrocaudal direction. Coronal slices were centered around
the infarction lesion, whereas horizontal slices were aligned
with the skullcap. DWIs were recorded with a multislice
Stejskal-Tanner spin-echo sequence: TR = 4000 msec, echo
time = 22 msec, field of view = 25 × 25 mm2, slice thick-
ness = 1 mm, matrix = 128 × 128. Data were recorded in the
same coronal and horizontal slices as chosen for T2WI. Two
sets of images were acquired with two different diffusion-
encoding gradient strengths (b = 30, 1000 s/mm2) in the
rostrocaudal direction. PWIs were performed with pulsed ar-
terial spin labeling (PASL) technique using a flow-sensitive
alternating inversion-recovery echo planar imaging (FAIR-
EPI) sequence with matrix = 96 × 96, FOV = 25 × 25 mm2,
inversion recovery time (TIR) = 30 to 2300 msec, number of
TIR values = 22, recovery time = 10,000msec, TE/TR > = 10/
18,000 msec. The T1 changes between slice selective inver-
sion sequence and nonselective inversion sequence were used
for CBF quantification [29]. The infarct volume and CBF ratio
weremeasured by using PMOD software (version 3.0; PMOD
Technologies). The CBF difference indexes (CBFDI) of the
infarct lesion, peri-infarct region, ipsilateral remote cortex,
and h ippocampus we re ca l cu l a t ed a s fo l l ows :
CBFDI = (CBF of the mirror site of contralateral
hemisphere–CBF of the selected region in the affected
hemisphere)/CBF of the mirror site of contralateral
hemisphere.
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Evaluation of Cerebral Glucose Metabolism
by MicroPET/CT Imaging
18F-FDG-PET/CT was performed to assess the evolutional
change of cerebral glucose utilization. After a 12-h fasting,
thrombotic stroke rats (n = 5) at 1, 3, 7, and 14 days were
anesthetized with isoflurane and intravenously administered
approximately 37 MBq (~1 mCi) of 18F-FDG. Sixty minutes
later, microPET/CT images were acquired for 30 min using a
FLEX X-PET and X-O small animal imaging system (GE
Healthcare) with the spatial resolution of 1.6 mm and the
voxel size of 0.4 mm × 0.4 mm × 1.2 mm. CT images were
acquired with 256 projections over 2 min for attenuation cor-
rection and anatomy landmarks. PET data were reconstructed
using 3D ordered subset expectation maximization (OSEM)
method. CT images were reconstructed using a cone-beam
reconstruction algorithm. PET and CT images were co-
registered using commercial software (Visage Imaging) with
72-μm isotropic CT spatial resolution and 2 mm for PET
imaging. For quantitative analysis, volume of interests
(VOIs) were drawn on the infarct lesion, one-voxel width
surrounding the lesion, and remote region on the ipsilateral
cortex. VOIs were also selected at the mirror sites of the con-
tralateral hemispheres. Percent-injected dose of 18F-FDG per
c.c. of brain tissue (%ID/cm3) was obtained from each VOI.
The metabolic difference index (MDI) of each VOI was cal-
culated with the following formula: MDI = (%ID/c.c. of con-
tralateral side VOI − %ID/c.c. of lesion VOI)/%ID/c.c. of
contralateral side VOI.
Assessment of Blood-Brain Barrier by EB Dye Staining
Disruption of BBB was evaluated at day 1, 3, 7, and 14 after
photothrombotic stroke induction. Briefly, 2 h after EB dye
(Sigma, 10 mg/ml in saline, 2.5 ml/kg rat weight) was injected
via tail vein, animals were sacrificed with an overdose of pen-
tobarbital injection (RMB, Animal Health Ltd., UK). The
brains were then removed from the skulls immediately after
death. To detect the presence of EB, the intact brain was im-
aged using in vivo fluorescence and bioluminescence imaging
system (IVIS 50, Perkin Elma, UK) with following steps and
image acquisition settings: the brains were placed at the center
of imaging field, and images were acquired for 2 s using Cy5.5
band pass filter channel (excitation/emission wavelength:
615~665 nm/695~770 nm). Region of interest (ROI) selection
and quantification were performed using living image software
3.2 (IVIS Imaging System, Perkin Elma, UK).
Statistical Analysis
The numerical data were reported as means ± standard devia-
tion (SD). Statistical analysis was carried out with the SPSS
for windows software package (release 13.0, SPSS Inc.,
Chicago IL). One-way ANOVA and Tukey post hoc test were
used to compare the MDIs and fluorescent signal intensity of
EB staining between different time points after stroke. A sig-
nificant difference was considered if the p value was less than
0.05.
Results
Cerebral Vascular Occlusion by Photothrombotic
Induction
Photochemical induction of embolic stroke was completed by
532-nm LASER illumination at somatosensory cortex
through the cranial window upon rose bengal infusion.
Vasoconstriction and blockade of blood flow were examined
by LSCI before and after stroke induction. As shown in Fig. 1,
the surface vessel network was clearly appeared before induc-
tion in each group. Thirty minutes after stroke induction, re-
markably vanishing of blood vessel network was observed in
rats injected with rose bengal through the cranial window
where the LASER beam illuminated at, while hyperemic
blood vessel network was presented in the group of only
Fig. 1 Laser speckle contrast imaging (LSCI) before and after photochemical induction of stroke. Cerebral vasculature occlusion was presented after
photothrombotic stroke. Either illumination of laser beam or sole injection of rose bengal did not block cerebral blood flow as shown on LSCI
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illuminated by laser beam and there was no change of blood
flow in the group of sole injection of rose bengal. The rapid
and massive coagulation of vessels within the illumination
area features the pathomechanism of this method which is
not similar to that in clinical ischemic stroke usually caused
by an embolus or two.
Tissue Viability and Morphological Characteristics
of Infarct Lesion
Tissue viability and morphologic change of the photochemi-
cally induced stroke were evaluated by TTC and H&E stains
at day 1, 3, 7, and 14 post-induction. Results of TTC and H&E
staining at each time point were shown in Fig. 2. TTC-
negative region which represents the necrotic and non-viable
tissue was well demonstrated on the first day after stroke in-
duction, and gradually decreased in size afterward. At day 3,
in addition to the shrinkage of ischemic lesion, the boundary
between TTC-positive and TTC-negative regions became
blurred, as compared to a sharp, clear dividing line at day 1,
indicating an increasing number of cells which were migrating
and infiltrating to the ischemic margin from outside the re-
gion. The volume of the infarct lesions at day 3 to day 14
reduced gradually and remarkably compared to that of the
initial infarct volume at day 1. TTC-negative region became
hardly observed at day 14 (Fig. 2a). Microscopic examination
of the H&E-stained tissues showed a typical stroke-induced
liquefactive necrosis at day 1, dilated vessels at day 3, infil-
tration of cells into the surrounding area of ischemia at days 3
and 7, and neovascular formation at day 14 (Fig. 2b, c).
The Change of Inflammatory Cells and Astrocytes
in Infarct Region
As a marker of macrophage and microglia, CD68 expression
represents the evolution of inflammatory response post-stroke
[30]. Figure 3a shows the presence of CD68-positive cells in
the border zone of infarction lesion at day 7, and the cell
number increased in the lesion at day 14. IHC staining using
antibody against GFAP showed the infiltration of astrocytes
into infarct boundary at day 7, and interdigitating compact
astrocyte scar surrounding the lesion core was observed at
day 14 (Fig. 3b). In addition, NeuN-expressing mature neuro-
nal cells were absent in stroke region throughout 14 days after
induction (Fig. 3c). These results indicated that the cellular
evolutional changes in the lesion were mainly the inflamma-
tory response and astrocyte scar formation, instead of
neurogenesis.
Angiogenesis and Vasculogenesis in Infarct Lesion
As shown in Fig. 4, there were scattered vWF (a marker of
endothelial cell) positive vessels in infarct boundary at day 3,
and the number of capillaries and αSMA (a marker of vascu-
lar smooth muscle cells) positive vessels significantly in-
creased along the infarct margin at day 7. Further, neovascu-
larization was detected in the core of infarct lesion at day 14.
These results suggested that angiogenesis and vasculogenesis
occurred in the regions of infarct and peri-infarct lesion within
2 weeks after photochemically induced stroke.
The Dynamic Evaluation of Brain Edema and CBF
To monitor the evolutional brain edema and hemodynamic
change of photothrombotic stroke, T2WI, DWI, and PWIwere
performed on rats at day 1, 3, 7, and 14 after stroke induction.
The ischemic lesion showed a hyperintensity in T2WI with
sharp margin at day 1, and the signals gradually declined
afterward (Fig. 5a). Quantitative analysis indicated that the
lesion volume declined from 11.4 mm3 at day 1 to 0.7 mm3
at day 14 (Fig. 5b). In DWI, restriction of water diffusion was
observed at the margin of stroke shown as an intense halo at
Fig. 2 Longitudinal TTC and H&E staining at day 1, 3, 7, and 14 after
induction of photochemical thrombosis. TTC-negative area, observed at
the site where laser illuminated, was largest in size at day 1, then
decreased with time, and was almost not detectable at day 14 (a). b–c
Morphological change in H&E-stained tissue sections. It showed a
typical stroke-induced liquefactive necrosis at day 1, dilated vessels at
day 3, infiltration of cells into the surrounding area of ischemia at days 3
and 7, and neovascular formation at day 14
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day 1 and day 3, but not in the core of the lesionwhich showed
a hypointense signal instead. At day 7, the halo was getting
smaller. The hypointense lesion almost completely disap-
peared at day 14 (Fig. 5a). As T2WI and DWI have been the
reliable methods for investigation of vasogenic edema and
cytotoxic edema, respectively [20, 21, 23], gradual reduction
of hypointense signal of T2WI and DWI suggested the im-
provement of brain edema, which contributed to decrease of
infarct volume. PWI at day 1 after photochemical induction
demonstrated a region of compromised CBF on arterial spin
labeling (ASL) corresponding to the photothrombotic infarct
lesion (6 ± 51 ml/100 g/min vs 200 ± 95 ml/100 g/min of
contralateral cortex), and slightly decreased CBF in the remote
cortex of ipsilateral hemisphere. The CBF compromised zone
was getting smaller with time. At day 14, a tiny infarct core
was still noted, suggesting a persisted damage of brain tissue.
CBF of the ischemic region recovered to 195 ± 55 ml/100 g/
min (Fig. 5c). CBFDI of the infarct region (zone A) and the
peri-infarct region (zone B) declined rapidly at day 7. CBFDIs
of the infarct region and the peri-infarct region showed no
significant difference with the contralateral cortex at day 7
and day 14, respectively. CBFDI of ipsilateral remote cortex
(zone C) and hippocampus (zone D) closed to zero means
CBF almost identical to that of the contralateral hemisphere
throughout the whole study of 14 days (Fig. 5d). In summary,
the MRI results revealed progressive shrinkage of stroke vol-
ume at the periphery of the infarct lesion early after stroke and
almost complete recovery of CBF within 2 weeks after stroke
induction. Moreover, the remarkable improvement of CBF in
infarct lesion and peri-infarct region at day 7 might be related
to the synchronous enhancement of angiogenesis and
vasculogenesis.
Glucose Metabolism of Stroke Lesion by 18F-FDG PET
Imaging
To investigate the metabolic change of the photochemically
induced brain stroke with time, 18F–FDG PET imaging was
performed at day 1, 3, 7, and 14 after induction of stroke. As
shown in Fig. 6a, a remarkably reduced 18F-FDG uptake was
noted at the site of infarct lesion and moderately reduced up-
take in the remote region of ipsilateral hemisphere at day 1
following induction of stroke. At day 3, the cortical metabolic
defect partially recovered in the outer region of the ischemic
Fig. 3 Immunohistochemical
staining of GFAP, CD68, and
NeuN at day 1, 3, 7, and 14 after
stroke induction. At day 7 post-
stroke, the result of staining
indicated that GFAP- and CD68-
positive cells accumulated at the
peri-infarct zone and formed a
belt surrounding the infarct lesion
at day 14. No NeuN expression
was observed in ischemic zone
throughout 14 days. Scale bar
100 μm
Fig. 4 Immunohistochemical
staining of vWF and αSMA at
day 1, 3, 7, and 14 after stroke
induction. Scattered vWF–vessels
were observed in the margin of
infarct zone at day 3, and the
number of vWF- and αSMA-
positive vasculature began to
increase at day 7. At day 14,
neovascularization notably
occurred in the core of infarct
zone
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zone and almost completely recovered in the remote cortex.
At day 14, the 18F-FDG uptake at the infarct site almost
completely recovered. MDI was calculated to monitor the
change of glucose utilization in the infarct lesion (zone A),
in the region at one-pixel width surrounding the lesion (zone
B), in the remote region of the ipsilateral cortex (zone C), as
well as in the hippocampus (zone D). MDIs of zones A and B
were decreasing with time, indicating that the glucose con-
sumption was gradually restored at both the infarct region
and the margin (Fig. 6b). There was significant decrease in
MDIs with time in zone A and zone B in 14 days (ANOVA,
p < 0.05). From day 7 to day 14, MDI of zone A decreased by
10% compared to 20% decrease in zone B, indicating that the
recovery of glucose metabolism at the margin of the infarct is
better than that in the infarct core. There was no significant
statistical difference of MDI observed for 14 days in zones C
and D (ANOVA, p > 0.05), suggesting no obvious compro-
mise of glucose metabolism observed in the ipsilateral remote
cortex and hippocampus. Using photothrombotic method, in-
farct induction at somatosensory cortex did not interfere the
glucose utilization in the remote ipsilateral cortex and hippo-
campus and contralateral cortex as well.
Evolution of BBB Permeability in Photothromboic Stroke
Evidence indicates that BBB disruption occurs after ischemic
stroke and leads to the leakage of normally excluded sub-
stances into interstitial fluid of the brain. To evaluate the extent
of BBB disruption and its restoration, we performed the EB
staining and ex vivo fluorescence imaging at day 1, 3, 7, and
14 post-stroke. Figure 7a demonstrated an infarction core
surrounded by an EB-stained zone in the somatosensory cor-
tex at day 1 after photochemical induction. Subsequently, the
leakage of BBB gradually increased at day 3 and began to
restore at day 7; a small EB-stained lesion still remained at
day 14. The ex vivo fluorescence imaging showed a high
intensity fluorescence corresponding to the EB-stained ische-
mic lesion. The fluorescence signals were much less intense
and less extensive at day 14. Quantitative analysis of EB fluo-
rescence at the ROIs of ischemic region showed a markedly
reduced signal intensity at day 14 compared to the highest
intensity at day 3 (Fig. 7b, p < 0.05). Fluorescent signal at
peri-infarct region was much lower than that at infarct core
throughout 7 days and greatly reduced to a background level
while the infarct core still showed a high signal at day 14.
These results suggest a favorable self-repair of BBB in 14 days
after photothrombotic stroke.
Discussion
In the present study, we have successfully assessed the
evolutional changes of cellular viability in the lesion, infarct
volume, brain edema, infiltration of inflammatory cells and
astrocytes, neovascularization, CBF, glucose metabolism,
and BBB permeability (Fig. 8). To the best of our knowledge,
this is the first study conducted using 18F-FDG/PET and MRI
to longitudinally evaluate the metabolic and hemodynamic
Fig. 5 Sequential images of T2WI, DWI, and PWI in stroke lesion on the
right somatosensory cortex and CBF analysis. a Images of T2WI, DWI,
and PWI at day 1, 3, 7, and 14 after ischemia induction demonstrated the
evolution of vasogenic edema and cytotoxic edema with time. b
Evolutional changes and CBFDI, which was calculated from the
regional CBF obtained from the PWI of the infarct lesion (zone A),
peri-lesional region (zone B, one-pixel width surrounding the infarct
lesion), ipsilateral remote cortex (zone C), and hippocampus (zone D).
It suggests that CBF of zone B improved more significantly than that of
zone A from day 7 after induction
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changes of the brain in the rat model of photochemically in-
duced cerebral infarction.
The method applied in current study was categorized as
Bend-artery occlusion in the cortex^ described by Chen et al.
[23]. It is the classical and simplest method of photochemical-
ly induced stroke model. Although this method can be
achieved with intact skull, however, to avoid the scatter and
reflection of light when illuminating through skull, a cranial
window was made before illumination. In this way, the infarc-
tion is anticipated to be more sharply demarcated and more
consistent in lesion size than using intact skull. Also, the vol-
ume of the ischemic lesion can be controlled by manipulating
the intensity of irradiating light and the size of irradiated zone
in the cranial window [11]. In the current study, a laser
beam of 532 nm wavelength was applied instead of arc
beam irradiated system with 560 nm wavelength. Less
intensity of the irradiating light causing less severity of
the induced stroke may account for the short period of
ipsilateral hypometabolism and lack of compromised glu-
cose utilization in contralateral cortex.
To confirm the success of photochemical induction, we
applied LSCI through the cranial window of the rat before
and after thrombosis was induced to assess the occlusion of
cerebral vasculature caused by photochemically induced
thrombosis. Laser speckle imaging is useful to assess cerebral
vasculature and CBF noninvasively with high temporal and
spatial resolution [28]. It has been used to study changes of
CBF after distal middle cerebral artery ligation in mice [31].
Upon photochemical induction, LSCI demonstrated blockade
of the majority of blood vessels in the illuminated region,
Fig. 6 Sequential 18F-FDG PET imaging of rats with photochemical
thrombosis on the right somatosensory cortex. a Transaxial
tomographic images at day 1, 3, 7, and 14 after stroke induction. b
Metabolic difference index (MDI) at ROIs of infarct zone (zone A),
one-pixel width surrounding the lesion (zone B, one-pixel width
surrounding the infarct lesion), remote region of the ipsilateral cortex
(zone C), and hippocampus (zone D) showed at each time point. There
was significant decrease in MDIs with time in zone A and zone B in
14 days (p < 0.05). Stroke rats, n = 5; shame rats, n = 3
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indicating successful induction of cerebral ischemia and/or
infarction.
In the evaluation of tissue viability and morphologic
change in infarct lesion, a wedge-shaped TTC-negative area
appeared at day 1 after stroke induction and the size gradually
reduced through day 3 to day 7 and was eventually not detect-
able at day 14. The result of H&E stain showed increased
number of infiltrated cells in infarct region since day 3, and
some cells were detected in the infarct core at day 14. The
identity of these infiltrated cells was further confirmed to be
macrophages, glial, endothelial, and smooth muscle cells, but
not neuronal cells by IHC staining. Infiltration of cells into the
infarct region caused the gradual shrinkage of TTC-negative
area.
Inflammation is strongly linked to the development of
stroke. Macrophages and microglia, two important types of
inflammatory cells in response to stroke, have significant ef-
fect on removing debris and activating inflammatory cascades
involved in repairing tissue damage [32, 33]. In the present
study, IHC staining showed that CD68 positive macrophages/
microglia and GFAP-expressing astrocytes notably accumu-
lated along the boundary of infarct lesion at day 14, forming a
belt consisting of inflammatory cells and astrocytes.
Simultaneously, some microglia/macrophages and astrocytes
were detected in the core of infarct lesion. Previous reports
suggested that astrocytes produce pro-inflammatory cytokines
and chemokines which subsequently recruit microglia/
macrophages for dead cell clearance [34, 35]. However, ex-
cessive inflammation may have adverse effect, i.e., inducing
free radicals which are harmful to neuronal cells [36]. Also,
excessive thickness of astrocyte-associated scar blocks neuro-
nal cells from migrating into the injured site. This evidence
further supports our result in which neuronal cells were not
detectable in the ischemic lesion throughout 14 days after
stroke induction.
Vasogenic edema examined by T2WI is strongly correlated
with BBB disruption after stroke [37, 38]. This was also ob-
served in present study. Hyperintensity in T2WI at day 1 and
day 3 post-stroke was paralleled with the intensity of EB fluo-
rescence, indicating the linkage between vasogenic edema and
BBB permeability in photothrombotic stroke. Serial DWI in
the current study revealed an intense halo located at the pe-
riphery of the stroke lesion seen on T2WI. This hyperintense
halo seen on DWI indicated the zone with cytotoxic edema
and began to gradually reduce since day 3 post-stroke. MR
images of photochemical stroke in a previous report also
showed early increase in T2 signal and decreased diffusion
of water, indicating the simultaneous development of substan-
tial vasogenic edema and ischemic infarction [39]. This pat-
tern is different from that seen in human stroke, where infarcts
develop with cytotoxic edema, followed by a vasogenic ede-
ma which is delayed by several hours [3].
The PWI demonstrated a region of absent CBF at the in-
farct site as well as the edematous region. CBFDI revealed
progressive restoration of CBF in the infarct zone and returned
to normal at day 14. CBF in the peri-infarct zone was less
compromised than that in the infarct zone and returned to
normal at day 7. The status of CBF was further confirmed
and well correlated with IHC results which showed dilated
vessels close to the infarct core at day 3 and neovasculariza-
tion at day 7 to 14.
In current study, progressive recovery of glucose utilization
was noted at the infarct lesion, peri-infarct zone, and ipsilateral
remote cortex. CBF recovery and progressive cell infiltration
subsequently causing enhancement of glucose utilization may
partially account for the rapid recovery of 18F-FDG uptake in
Fig. 7 Detection of blood-brain barrier disruption by EB staining. a
Representative images of EB staining and fluorescence imaging of rat
brain at day 1, 3, 7, and 14 after ischemia induction. b Quantitative
analysis of EB fluorescence at the ROIs of ischemic region (n = 3 at
each time point). It suggested that the leakage of BBB was most
remarkable at day 3 and was subsequently decreasing with time
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the infarct zone and its vicinity. Analysis of the MDI is more
sensitive than visual inspection of hypometabolic lesion. MDI
at day 14 revealed relatively higher restoration of glucose
consumption at the peri-infarct zone than that in the infarct
core (10 vs 20 %, respectively). Several preclinical studies of
small animal ischemic stroke models have consistently re-
vealed an increased 18F-FDG uptake in the peri-infarct regions
due to the effects of activation of glucose transporters, hexo-
kinase, and neuroinflammation [40]. Previous study which
used the model of photothrombotic MCAo in rats showed that
18F-FDG uptake in the peri-ischemic areas was comparable to
the normal brain regions at day 1 and 3 and notably elevated at
days 7 and 14 [41]. In the present study, glucose utilization in
the peri-infarct region was decreased compared to that in the
normal region throughout 14 days after stroke induction.
However, progressive recovery of glucose utilization in this
region was noted. These different results of glucose metabo-
lism in peri-infarct area might attribute to different animal
stroke models, time of evaluation, and imaging techniques.
It is commonly agreed that no salvageable penumbral tis-
sue exists in the model of photochemically induced stroke.
This disadvantageous phenomenon of this model is different
to that of other embolic models where penumbra is muchmore
like those in human stroke and much larger. Hilger and col-
leagues named peri-infarct zone of photothrombotic stroke as
Bregion-at-risk,^ where a little viable cells, low energy metab-
olism, and vasogenic edema existed [42]. In present study, the
number of inflammatory cells and astrocytes, as well as neo-
vascularization, gradually increased in peri-infarct region. At
day 14, a belt consisting of inflammatory cells and astrocytes
was observed surrounding the infarct lesion. In addition,
vasogenic edema and cytotoxic edema progressively reduced,
and CBF and glucose metabolism gradually improved. The
leakage of EB dye at the peri-infarct zone significantly re-
duced than that in the infarct core. These data suggests the
recoverable BBB leakage, neovascularization, CBF, and glu-
cose metabolism at peri-infarct region rather than at infarct
core.
Although we have longitudinally characterized the patho-
physiological changes of photothrombotic brain ischemia by
multiple imaging modalities and cellular immunostaining,
some limitations should be addressed in the current study.
First, photochemically induced occlusion occurred in vessels
within the irradiation area, where the mechanism is different
from that of clinical ischemic stroke which was usually caused
by an embolus or two. Only a little or no local collateral flow/
reperfusion and ischemic penumbra occur in this model.
Despite that the cellular changes in this model are still evolv-
ing and follow a similar trend to those of other occlusive
models, the pathomechanism is different from those seen in
human stroke. Second, evaluationwas not performed at earlier
time points (3–12 h post-stroke) due to poor animal condition
early after stroke induction for 18F-FDG/PET and MRI exam-
ination. Sequential assessment of the evolutional change of
Fig. 8 Evolutional characterization of photochemically induced stroke. The changes of tissue viability, infarct lesion volume, brain edema,
inflammatory cells and astrocyte infiltration, neovascularization, CBF, glucose metabolism, and BBB permeability at each time point were summarized
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photochemically induced rat stroke model during the first 24 h
following stroke will be carried out in the future study. Third,
we did not perform quantitation of blood flow of regional
cerebral vasculature by LSCI because the measurement of
CBF is limited to the superficial cortex. Fourth, the experi-
ments of multi-modality imaging were performed on the same
animal as possible as we could for serial imaging protocol.
However, to avoid being anesthetized for a long period of time
on the same animal, PET and MRI imaging were not per-
formed on the same day. Despite these drawbacks and limita-
tions of thismodel, the advantages of easymanipulation, high-
ly reproducible, lesion controllable, and low mortality have
made this method comprehensively applied. Further, the con-
sistent lesion made in the cortex where cellular changes
evolve and follow a similar trend to those of the occlusive
models makes it a suitable model for the study of
neurorestorative therapy of pharmaceuticals or stem cells. In
the scope of translational purpose, this method had been ap-
plied on animals other than rodents, such as rabbits and pigs
[43–46].
Conclusion
The evolution of photochemically induced stroke model in
rats has been longitudinally characterized for 14 days by
18F-FDG/PET, MRI, IVIS, histopathology, and immunohisto-
chemistry examination. Within 14 days after stroke induction,
we found the occurrence of early brain edema, infiltration of
inflammatory cells and astrocytes, neovascularization in the
infarct core and peri-infarct zone, improvement of CBF, glu-
cose metabolism, and BBB permeability. These serial changes
characterized in this study provide better understanding of
cerebral ischemia and are highly beneficial to the development
of therapeutic strategies for ischemic stroke.
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